(Bloomberg) -- Nova Biomedical is exploring a potential sale that could value it at more than $2 billion, people with knowledge of the matter said. The privately-held medical device maker is ...
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Nova Eye Medical Limited (EYE). However, you won't necessarily see their names in the company’s ...
The Nova Primary blood glucose reference analyzer meets the requirements of glucose device manufacturers and clinical researchers for an accurate, user-friendly replacement for the discontinued ...